Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Inflatable Aortic Valve Reduces Aortic Regurgitation

By HospiMedica International staff writers
Posted on 03 Dec 2012
An innovative transcatheter aortic valve (TAV) system virtually eliminates aortic regurgitation with no vascular complications. More...


The Direct Flow Medical (DFM) TAV System percutaneous aortic valve is designed to have the performance of a surgical valve with the attributes for transcatheter delivery, with the additional ability to be positioned, repositioned, and completely retrieved if necessary. The valve is based on an inflatable cuff with a conforming polymer support structure. Inflatable ventricular and aortic rings at the top and bottom of the valve are designed to conform and seal above and below the native valve. The lack of a metallic frame allows for a low profile, flexible, fully-sheathed system with the potential to reduce bleeding and vascular complications, particularly in patients with tortuous and variable anatomy. The valve is endovascularly delivered via a six mm introducer sheath.

The independently inflatable rings encircle and capture the native valve annulus to provide positive axial anchoring of the device. Inflation of the cuff with a saline and contrast solution renders the valve immediately functional and permits fluoroscopic visualization. Before final deployment, the saline and contrast mixture is exchanged under pressure, maintaining cuff shape and position, with a solidifying inflation media (IM) that hardens to form the permanent support structure. Full-thickness bovine pericardial leaflets are incorporated in the valve design for durability. The DFM TAV System is a product of Direct Flow Medical (Santa Rosa, CA, USA), and is currently approved as an investigational device.

“We designed the Direct Flow Medical System specifically to address complications that were problematic with earlier generations of transcatheter aortic heart valves,” said Charles Davidson, MD, clinical chief of cardiology at Northwestern Memorial Hospital (Chicago, IL, USA), and chief medical officer of Direct Flow Medical. “Our proprietary design takes a very different approach to restoring valvular flow, while being fully repositionable and retrievable.”

Related Links:
Direct Flow Medical
Northwestern Memorial Hospital


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Portable Jaundice Management Device
Nymphaea
Spirometry & Oximetry Software
MIR Spiro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.